Hypogastric and/or perineal pain-relieving agent
A pharmaceutical composition for improving chronic pelvic cavity pain syndrome due to urinary dysfunction where said composition contains tamsulosin or pharmaceutically acceptable salts thereof.
1 . A pharmaceutical composition for improving chronic pelvic cavity pain syndrome due to urinary dysfunction where said composition contains tamsulosin or pharmaceutically acceptable salts thereof.
2 . A pharmaceutical composition for improving hypogastric/perineal pain due to a state of decreased urine production where said composition contains tamsulosin or pharmaceutically acceptable salts thereof.
3 . A pharmaceutical composition for improving chronic pelvic cavity pain syndrome due to urinary dysfunction according to claim 1 where said composition contains tamsulosin hydrochloride.
4 . Use of tamsulosin or a pharmaceutically acceptable salt thereof for the manufacture of a therapeutic agent for improving chronic pelvic cavity pain syndrome due to urinary dysfunction.
5 . Use of tamsulosin or a pharmaceutically acceptable salt thereof for the manufacture of a therapeutic agent for improving hypogastric/perineal pain or lower backache due to a state of decreased urine production.
6 . A method for the therapy of chronic pelvic cavity pain syndrome due to urinary dysfunction, where said method includes the administration of effective therapeutic doses of tamsulosin or a pharmaceutically acceptable salt thereof to patients.
7 . A method for the therapy of hypogastric/perineal pain or lower backache due to a state of decreased urine production, where said method includes the administration of effective therapeutic doses of tamsulosin or a pharmaceutically acceptable salt thereof to patients.